POST-APPROVAL SAFETY STUDY (PASS) OF THE UTILIZATION PATTERN OF APIXABAN IN SWEDENFirst published 19/11/2013 Last updated 13/03/2024 EU PAS number: EUPAS5177StudyFinalised